高级搜索

含氧多环芳烃促肝癌细胞侵袭转移过程中Hippo通路作用探究

,  ,  , 

downloadPDF

上一篇

下一篇

高瑞, 武秀瑜, 蔡知洪, 桑楠. 含氧多环芳烃促肝癌细胞侵袭转移过程中Hippo通路作用探究[J]. 环境化学, 2024, 43(4): 1118-1126. doi: 10.7524/j.issn.0254-6108.2023042101
引用本文: 高瑞, 武秀瑜, 蔡知洪, 桑楠. 含氧多环芳烃促肝癌细胞侵袭转移过程中Hippo通路作用探究[J]. 环境化学, 2024, 43(4): 1118-1126. doi: 10.7524/j.issn.0254-6108.2023042101
shu
GAO Rui, WU Xiuyu, CAI Zhihong, SANG Nan. Role of Hippo pathway in promoting invasion and metastasis of liver cancer cells by oxygenated polycyclic aromatic hydrocarbons[J]. Environmental Chemistry, 2024, 43(4): 1118-1126. doi: 10.7524/j.issn.0254-6108.2023042101
Citation: GAO Rui, WU Xiuyu, CAI Zhihong, SANG Nan. Role of Hippo pathway in promoting invasion and metastasis of liver cancer cells by oxygenated polycyclic aromatic hydrocarbons[J]. Environmental Chemistry, 2024, 43(4): 1118-1126. doi: 10.7524/j.issn.0254-6108.2023042101
shu

含氧多环芳烃促肝癌细胞侵袭转移过程中Hippo通路作用探究

  • 1.

    山西医科大学法医学院，晋中，030600

  • 2.

    山西大学环境与资源学院，太原，030006

    • 通讯作者: Tel：0351-7018696，E-mail：sangnan@sxu.edu.cn
  • 基金项目:
    国家自然科学基金（22106097），山西省基础研究计划青年项目（20210302124059）和山西省高等学校科技创新项目资助.

Role of Hippo pathway in promoting invasion and metastasis of liver cancer cells by oxygenated polycyclic aromatic hydrocarbons

  • 1.

    School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, China.

  • 2.

    College of Environmental and Resource Sciences, Shanxi University, Taiyuan, 030006, China

    • Corresponding author: SANG Nan, sangnan@sxu.edu.cn
  • Fund Project: the National Natural Science Foundation of China (22106097), Fundamental Research Program of Shanxi Province (20210302124059) and Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi.

  • 摘要: 由于氧化官能团的存在，含氧多环芳烃（oxy-PAHs）比母体多环芳烃具有更高的极性、溶解度、迁移率和生物反应活性，在环境中的分布更为广泛. 许多oxy-PAHs具有更高的遗传毒性、促肿瘤活性和发育毒性，而目前关于其促肿瘤活性作用机制的研究较少. Hippo-YAP通路被发现是调节癌细胞免疫、增殖、转移等的关键因子. 本研究基于肝癌细胞暴露模型，对环境含量丰富的含氧多环芳烃（9-芴酮）的促肿瘤作用及Hippo-YAP调控机制进行了探究. 结果发现，较高浓度9-芴酮(9-Fluorenone)暴露可促进肝癌细胞侵袭、迁移及上皮间质转化（EMT）的发生，且Hippo-YAP通路在9-Fluorenone促肿瘤过程中有重要作用. 具体而言，9-Fluorenone暴露可通过诱导Hippo上游激酶MST、LATS以及YAP蛋白的去磷酸化，未磷酸化的YAP可以直接进入细胞核内与TEAD结合，调控下游EMT的发生，进而促进侵袭转移. 本研究结果为含氧多环芳烃的促肿瘤活性研究提供了实验基础，对于全面评估多环芳烃及衍生物的生态和健康风险具有重要参考作用.
    Abstract: Due to the presence of oxygenated functional groups, oxygenated polycyclic aromatic hydrocarbons (oxy-PAHs) possess higher polarity, solubility, mobility, and biological reactivity than their parent PAHs, and are more widely distributed in the environment. Although numerous oxy-PAHs exhibit heightened genotoxicity, carcinogenicity, and developmental toxicity, limited research has been conducted to elucidate the underlying mechanisms responsible for their tumorigenic promotion. Notably, the Hippo-YAP pathway has emerged as a pivotal regulatory process governing cancer cell immunity, proliferation, and metastasis. In this study, the tumor promoting effect of oxy-PAHs (specifically 9-Fluorenone) that are commonly found in the environment, as well as the underlying Hippo-YAP regulation mechanism were investigated by using the liver cancer cell exposure model. The results showed that a high concentration of 9-Fluorenone exposure significantly enhanced the invasion, migration, and epithelial-mesenchymal transition (EMT) of HepG2 cells, and the Hippo-YAP pathway was identified as playing a crucial role in the tumor-promoting process. Specifically, 9-Fluorenone exposure can induce dephosphorylation of upstream kinases in the Hippo pathway, such as MST and LATS, and then induce dephosphorylation of YAP. Consequently, YAP is able to bind to TEAD in the nucleus, thereby regulating the occurrence of EMT and ultimately promoting the invasion and metastasis of cancer cells. This study contributes valuable toxicological evidence supporting the tumor-promoting effect of oxy-PAHs and holds significant reference value for the comprehensive assessment of the ecological and health risks associated with PAHs and their derivatives.
  • 加载中

  • 图 1  9-Fluorenone暴露诱导肝癌细胞侵袭和迁移的发生(*** P＜0.001)

    Figure 1.  The invasion and migration of hepatocellular carcinoma cells induced by 9-Fluorenone exposure(*** P＜0.001)

    下载: 全尺寸图片 幻灯片

    图 2  9-Fluorenone暴露诱导肝癌细胞EMT发生(** P＜0.01)

    Figure 2.  The epithelial-mesenchymal transition （EMT） of hepatocellular carcinoma cells induced by 9-Fluorenone exposure(** P＜0.01)

    下载: 全尺寸图片 幻灯片

    图 3  9-Fluorenone暴露通过肝癌细胞MST-LATS级联效应诱导Hippo-YAP通路失调(* P＜0.05, ** P＜0.01)

    Figure 3.  9-Fluorenone exposure disrupted the MST-LATS cascade and induced Hippo-YAP pathway dysfunction in hepatocellular carcinoma cells(* P＜0.05, ** P＜0.01)

    下载: 全尺寸图片 幻灯片

    图 4  9-Fluorenone暴露诱导肝癌细胞YAP-TEAD的结合

    Figure 4.  9-Fluorenone exposure induced the interaction of YAP and TEAD in hepatocellular carcinoma cells

    下载: 全尺寸图片 幻灯片

    图 5  YAP-TEAD抑制剂处理对9-Fluorenone诱导的肝癌细胞EMT和侵袭转移效应的影响(与对照组比较**P<0.01, ***P<0.001; 与9-F组比较 #P<0.05)

    Figure 5.  The effects of YAP-TEAD inhibitor treatment on EMT and invasion and metastasis of hepatocellular carcinoma cells induced by 9-Fluorenone(**P<0.01,***P<0.001 vs control group；＃P<0.05 vs 9-FL group)

    下载: 全尺寸图片 幻灯片

    表 1  PCR扩增引物序列

    Table 1.  The primer sequences for PCR amplification

    基因名称
    Gene name    		 引物序列 （5’-3’）
    Primer sequences （5’-3’）
    β-actin Forward: CTGGAACGGTGAAGGTGACA
    Reverse: AAGGGACTTCCTGTAACAATGCA
    E-cadherin Forward: AATGCCGCCATCGCTTAC
    Reverse: AGGCACCTGACCCTTGTA
    Fibronectin Forward: AGGAGCACCACCCCAGACATTACT
    Reverse: CCAGGCCGGGACTCAGGTTAT
    基因名称
    Gene name    		 引物序列 （5’-3’）
    Primer sequences （5’-3’）
    β-actin Forward: CTGGAACGGTGAAGGTGACA
    Reverse: AAGGGACTTCCTGTAACAATGCA
    E-cadherin Forward: AATGCCGCCATCGCTTAC
    Reverse: AGGCACCTGACCCTTGTA
    Fibronectin Forward: AGGAGCACCACCCCAGACATTACT
    Reverse: CCAGGCCGGGACTCAGGTTAT
    下载: 导出CSV
  • [1] ACHTEN C, ANDERSSON J T. Overview of polycyclic aromatic compounds (PAC)[J]. Polycyclic Aromatic Compounds, 2015, 35(2/3/4): 177-186.
    [2] SÁNCHEZ-ARÉVALO C M, OLMO-GARCÍA L, FERNÁNDEZ-SÁNCHEZ J F, et al. Polycyclic aromatic hydrocarbons in edible oils: An overview on sample preparation, determination strategies, and relative abundance of prevalent compounds[J]. Comprehensive Reviews in Food Science and Food Safety, 2020, 19(6): 3528-3573. doi: 10.1111/1541-4337.12637
    [3] GE Y X, WU S M, YAN K. Concentrations, influencing factors, risk assessment methods, health hazards and analyses of polycyclic aromatic hydrocarbons in dairies: A review[J]. Critical Reviews in Food Science and Nutrition, 2022: DOI: 10.1080/10408398.2022.2028717.
    [4] ZHANG Y J, CHEN X Q, ZHANG Y. Analytical chemistry, formation, mitigation, and risk assessment of polycyclic aromatic hydrocarbons: From food processing to in vivo metabolic transformation[J]. Comprehensive Reviews in Food Science and Food Safety, 2021, 20(2): 1422-1456. doi: 10.1111/1541-4337.12705
    [5] ANDERSSON J T, ACHTEN C. Time to say goodbye to the 16 EPA PAHs? toward an up-to-date use of PACs for environmental purposes[J]. Polycyclic Aromatic Compounds, 2015, 35(2/3/4): 330-354.
    [6] LARA S, VILLANUEVA F, MARTÍN P, et al. Investigation of PAHs, nitrated PAHs and oxygenated PAHs in PM10 urban aerosols. A comprehensive data analysis[J]. Chemosphere, 2022, 294: 133745. doi: 10.1016/j.chemosphere.2022.133745
    [7] QIAO M, QI W X, LIU H J, et al. Oxygenated polycyclic aromatic hydrocarbons in the surface water environment: Occurrence, ecotoxicity, and sources[J]. Environment International, 2022, 163: 107232. doi: 10.1016/j.envint.2022.107232
    [8] ZASTROW L, JUDAS M, SPEER K, et al. Barbecue conditions affect contents of oxygenated and non-oxygenated polycyclic aromatic hydrocarbons in meat and non-meat patties[J]. Food Chemistry:X, 2022, 14: 100351. doi: 10.1016/j.fochx.2022.100351
    [9] MA S T, LIN M Q, TANG J, et al. Occurrence and fate of polycyclic aromatic hydrocarbons from electronic waste dismantling activities: A critical review from environmental pollution to human health[J]. Journal of Hazardous Materials, 2022, 424: 127683. doi: 10.1016/j.jhazmat.2021.127683
    [10] CLERGÉ A, Le GOFF J, LOPEZ C, et al. Oxy-PAHs: Occurrence in the environment and potential genotoxic/mutagenic risk assessment for human health[J]. Critical Reviews in Toxicology, 2019, 49(4): 302-328. doi: 10.1080/10408444.2019.1605333
    [11] WINCENT E, JÖNSSON M E, BOTTAI M, et al. Aryl hydrocarbon receptor activation and developmental toxicity in zebrafish in response to soil extracts containing unsubstituted and oxygenated PAHs[J]. Environmental Science & Technology, 2015, 49(6): 3869-3877.
    [12] GEIER M C, CHLEBOWSKI A C, TRUONG L, et al. Comparative developmental toxicity of a comprehensive suite of polycyclic aromatic hydrocarbons[J]. Archives of Toxicology, 2018, 92(2): 571-586. doi: 10.1007/s00204-017-2068-9
    [13] McCARRICK S, CUNHA V, ZAPLETAL O, et al. In vitro and in vivo genotoxicity of oxygenated polycyclic aromatic hydrocarbons[J]. Environmental Pollution, 2019, 246: 678-687. doi: 10.1016/j.envpol.2018.12.092
    [14] ALBINET A, LEOZ-GARZIANDIA E, BUDZINSKI H, et al. Polycyclic aromatic hydrocarbons (PAHs), nitrated PAHs and oxygenated PAHs in ambient air of the Marseilles area (South of France): Concentrations and sources[J]. Science of the Total Environment, 2007, 384(1/2/3): 280-292.
    [15] ZHU T, RAO Z, GUO F, et al. Simultaneous determination of 32 polycyclic aromatic hydrocarbon derivatives and parent PAHs using gas chromatography-mass spectrometry: Application in groundwater screening[J]. Bulletin of Environmental Contamination and Toxicology, 2018, 101(5): 664-671. doi: 10.1007/s00128-018-2462-x
    [16] 朱超飞, 武姿辰, 杨文龙, 等. 土壤中有机污染物的气相色谱-四极杆飞行时间质谱非靶标筛查[J]. 环境化学, 2021, 40(2): 662-664.

    ZHU C F, WU Z C, YANG W L, et al. Non-target screening of organic pollutants in soil based on GC-QTOF/MS[J]. Environmental Chemistry, 2021, 40(2): 662-664.

    [17] BANDOWE B A M, LUESO M G, WILCKE W. Oxygenated polycyclic aromatic hydrocarbons and azaarenes in urban soils: A comparison of a tropical city (Bangkok) with two temperate cities (Bratislava and Gothenburg)[J]. Chemosphere, 2014, 107: 407-414. doi: 10.1016/j.chemosphere.2014.01.017
    [18] YUN Y, ZHANG Y J, LI G K, et al. Embryonic exposure to oxy-polycyclic aromatic hydrocarbon interfere with pancreatic β-cell development in zebrafish via altering DNA methylation and gene expression[J]. The Science of the Total Environment, 2019, 660: 1602-1609. doi: 10.1016/j.scitotenv.2018.12.476
    [19] LI D, YUN Y, GAO R. Oxygenated Polycyclic aromatic hydrocarbons (Oxy-PAHs) facilitate lung cancer metastasis by epigenetically regulating the epithelial-to-mesenchymal transition (EMT) [J]. Environmental Pollution, 2019, 255(Pt 2): 113261.
    [20] LI F L, GUAN K L. The two sides of Hippo pathway in cancer[J]. Seminars in Cancer Biology, 2022, 85: 33-42. doi: 10.1016/j.semcancer.2021.07.006
    [21] WANG R C, ZHU G Q. A narrative review for the Hippo-YAP pathway in cancer survival and immunity: The Yin-Yang dynamics[J]. Translational Cancer Research, 2022, 11(1): 262-275. doi: 10.21037/tcr-21-1843
    [22] HARVEY K F, ZHANG X M, THOMAS D M. The Hippo pathway and human cancer[J]. Nature Reviews Cancer, 2013, 13(4): 246-257. doi: 10.1038/nrc3458
    [23] SANCHEZ-VEGA F, MINA M, ARMENIA J, et al. Oncogenic signaling pathways in the cancer genome atlas[J]. Cell, 2018, 173(2): 321-337.
    [24] HUANG J B, WU S A, BARRERA J, et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP[J]. Cell, 2005, 122(3): 421-434. doi: 10.1016/j.cell.2005.06.007
    [25] KOO J H, GUAN K L. Interplay between YAP/TAZ and metabolism[J]. Cell Metabolism, 2018, 28(2): 196-206. doi: 10.1016/j.cmet.2018.07.010
    [26] ZHAO B, WEI X M, LI W Q, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control[J]. Genes & Development, 2007, 21(21): 2747-2761.
    [27] ZHANG H, LIU C Y, ZHA Z Y, et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition[J]. The Journal of Biological Chemistry, 2009, 284(20): 13355-13362. doi: 10.1074/jbc.M900843200
    [28] INAMOTO T, AZUMA H, SAKAMOTO T, et al. Invasive ability of human renal cell carcinoma cell line Caki-2 is accelerated by gamma-aminobutyric acid, via sustained activation of ERK1/2 inducible matrix metalloproteinases[J]. Cancer Investigation, 2007, 25(7): 574-583. doi: 10.1080/07357900701522471
    [29] XU Q, XU H X, LI J P, et al. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling[J]. Oncotarget, 2017, 8(10): 16972-16987. doi: 10.18632/oncotarget.15216
    [30] SHEN J, CAO B B, WANG Y T, et al. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer[J]. Journal of Experimental & Clinical Cancer Research:CR, 2018, 37(1): 175.
    [31] LI H L, LI Q Y, JIN M J, et al. A review: Hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression[J]. Journal of Cancer Research and Clinical Oncology, 2021, 147(6): 1569-1585. doi: 10.1007/s00432-021-03604-8
    [32] GAO R, LI D, YUN Y, et al. Dysfunction of the hippo-yap pathway drives lung cancer metastasis induced by 1-nitropyrene through adhesion molecular activation[J]. Environmental Science & Technology Letters, 2019, 6(5): 270-276.
    [33] LAYSHOCK J A, WILSON G, ANDERSON K A. Ketone and quinone-substituted polycyclic aromatic hydrocarbons in mussel tissue, sediment, urban dust, and diesel particulate matrices[J]. Environmental Toxicology and Chemistry, 2010, 29(11): 2450-2460. doi: 10.1002/etc.301
    [34] BANDOWE B A, WILCKE W. Analysis of polycyclic aromatic hydrocarbons and their oxygen-containing derivatives and metabolites in soils[J]. Journal of Environmental Quality, 2010, 39(4): 1349-1358. doi: 10.2134/jeq2009.0298
    [35] GAO R,JIANG Z H,WU X Y,et al. Metabolic regulation of tumor cells exposed to different oxygenated polycyclic aromatic hydrocarbons.[J]. Science of the Total Environment, 2024, 907: 167833.
    [36] OTSUKI Y, SAYA H, ARIMA Y. Prospects for new lung cancer treatments that target EMT signaling[J]. Developmental Dynamics, 2018, 247(3): 462-472. doi: 10.1002/dvdy.24596
    [37] LIU Y, LIU B, ZHANG G Q, et al. Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition[J]. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2018, 391(7): 695-704. doi: 10.1007/s00210-018-1499-z
    [38] ZYGULSKA A L, KRZEMIENIECKI K, PIERZCHALSKI P. Hippo pathway - brief overview of its relevance in cancer[J]. Journal of Physiology and Pharmacolog, 2017, 68(3): 311-335.
    [39] HAN H, NAKAOKA H J, HOFMANN L, et al. The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1[J]. Nature Cell Biology, 2022, 24(1): 74-87. doi: 10.1038/s41556-021-00813-8
    [40] AKRIDA I, BRAVOU V, PAPADAKI H. The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer[J]. Molecular Biology Reports, 2022, 49(10): 10065-10076. doi: 10.1007/s11033-022-07590-z
    [41] BARRETTE A M, RONK H, JOSHI T, et al. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models[J]. Neuro-oncology, 2022, 24(5): 694-707. doi: 10.1093/neuonc/noab244
    [42] GAO R, YUN Y, CAI Z H, et al. PM2.5-associated nitro-PAH exposure promotes tumor cell metastasis through Hippo-YAP mediated transcriptional regulation[J]. The Science of the Total Environment, 2019, 678: 611-617. doi: 10.1016/j.scitotenv.2019.04.420
    [43] CHANG J H, LEE Y L, LAIMAN V, et al. Air pollution-regulated E-cadherin mediates contact inhibition of proliferation via the hippo signaling pathways in emphysema[J]. Chemico-Biological Interactions, 2022, 351: 109763. doi: 10.1016/j.cbi.2021.109763
    [44] CHUNG Y L, LAIMAN V, TSAO P N, et al. Diesel exhaust particles inhibit lung branching morphogenesis via the YAP/TAZ pathway[J]. The Science of the Total Environment, 2023, 861: 160682. doi: 10.1016/j.scitotenv.2022.160682
  • 加载中
WeChat 点击查看大图
图( 5) 表( 1)
计量
  • 文章访问数:  706
  • HTML全文浏览数:  706
  • PDF下载数:  20
  • 施引文献:  0
出版历程
  • 收稿日期:  2023-04-21
  • 录用日期:  2023-07-26
  • 刊出日期:  2024-04-27

含氧多环芳烃促肝癌细胞侵袭转移过程中Hippo通路作用探究

    通讯作者: Tel：0351-7018696，E-mail：sangnan@sxu.edu.cn
  • 1. 山西医科大学法医学院，晋中，030600
  • 2. 山西大学环境与资源学院，太原，030006
  • 收稿日期:  2023-04-21
  • 录用日期:  2023-07-26
  • 网络出版日期:  2024-04-17
基金项目:
国家自然科学基金（22106097），山西省基础研究计划青年项目（20210302124059）和山西省高等学校科技创新项目资助.

摘要: 由于氧化官能团的存在，含氧多环芳烃（oxy-PAHs）比母体多环芳烃具有更高的极性、溶解度、迁移率和生物反应活性，在环境中的分布更为广泛. 许多oxy-PAHs具有更高的遗传毒性、促肿瘤活性和发育毒性，而目前关于其促肿瘤活性作用机制的研究较少. Hippo-YAP通路被发现是调节癌细胞免疫、增殖、转移等的关键因子. 本研究基于肝癌细胞暴露模型，对环境含量丰富的含氧多环芳烃（9-芴酮）的促肿瘤作用及Hippo-YAP调控机制进行了探究. 结果发现，较高浓度9-芴酮(9-Fluorenone)暴露可促进肝癌细胞侵袭、迁移及上皮间质转化（EMT）的发生，且Hippo-YAP通路在9-Fluorenone促肿瘤过程中有重要作用. 具体而言，9-Fluorenone暴露可通过诱导Hippo上游激酶MST、LATS以及YAP蛋白的去磷酸化，未磷酸化的YAP可以直接进入细胞核内与TEAD结合，调控下游EMT的发生，进而促进侵袭转移. 本研究结果为含氧多环芳烃的促肿瘤活性研究提供了实验基础，对于全面评估多环芳烃及衍生物的生态和健康风险具有重要参考作用.

English Abstract

    全文HTML

  • 多环芳烃（PAHs）广泛分布于大气、土壤、水、生活垃圾等各种环境中，由于具有遗传毒性和致癌活性，它们在食品和环境中的污染水平受到严格监管[1 − 4]. 含氧多环芳烃（oxy-PAHs）、硝基多环芳烃、烷基多环芳烃等衍生物通常与PAHs共同存在，其排放源与PAHs相似，主要包括化石燃料的不完全燃烧、汽车尾气排放以及多环芳烃的光化学与生物转化作用等[5]. 由于具有高极性、高水溶性、低蒸汽压等特点，oxy-PAHs在水、土壤、大气颗粒物等环境中的分布比母体PAHs更为广泛[6 − 7]. 且在各种食物以及电子垃圾等环境中也检测到较高浓度的oxy-PAHs[8 − 9]. 最近研究表明，与PAH相比，许多oxy-PAHs具有更高的遗传毒性、促肿瘤活性、发育毒性、心血管毒性和细胞毒性[10 − 13]. 然而，目前有关oxy-PAHs的毒性作用机制研究主要集中于遗传毒性、发育毒性等，对其促肿瘤活性作用机制的研究甚少.

    9-芴酮（9-Fluorenone）是大气和水环境中含量最为丰富的oxy-PAHs之一，在多种环境介质中均有检出. 例如，法国南部地区大气环境中9-Fluorenone含量约占oxy-PAHs总浓度的60%[14]. 汽车尾气颗粒物中9-Fluorenone含量明显高于其他oxy-PAHs[10]. 我国多个地下水样本中均检出大量9-Fluorenone[15]. 对宜昌市化工园区的土壤样品有机污染物进行非靶标筛查中发现了9-Fluorenone的存在[16]. 此外，研究发现9-Fluorenone是矿质土壤和燃烧排放中最丰富的oxy-PAHs之一[17]. 目前，有关9-Fluorenone的毒性研究主要集中于发育毒性、遗传毒性等[18]，有关9-Fluorenone的促癌作用研究较少. 本课题组前期研究发现，9-Fluorenone暴露可诱导肺癌细胞EMT的发生进而促进侵袭转移[19]，但关于9-Fluorenone的促癌作用机制仍不明确.

    Hippo-YAP通路被发现是调节癌细胞存活、增殖、转移、免疫、凋亡等的关键因子[20 − 21]. 与大量动物研究结果一致，美国TCGA（The Cancer Genome Atlas，癌症基因组图谱）项目对9125个肿瘤样本进行了多组学分析，结果表明Hippo通路失调发生在多种人类癌症中[22 − 23]. Hippo信号通路是一个激酶级联通路，主要作用是调节Yes相关蛋白（YAP和TAZ）、转录共激活因子和效应靶标分子. Hippo信号通路开始于肿瘤抑制性丝氨酸/苏氨酸激酶（MST1/2）的激活，然后磷酸化并激活大肿瘤抑制因子（LATS1/2），进而磷酸化并抑制YAP（Yes相关蛋白）向细胞核的转移[24]. 当Hippo信号通路受刺激失活时，MST1/2与LATS1/2的磷酸化激活被抑制，使得未磷酸化的YAP转移至细胞核以调节癌细胞增殖转移等相关靶基因的表达[25]. Hippo通路异常与肿瘤细胞的迁移和侵袭密切相关，Hippo通路的关键效应分子YAP和TAZ的异常积累和核转移在转移性肿瘤中经常发生[26]. YAP作为细胞核内TEAD等转录因子的共激活因子，可以调控肿瘤转移相关基因的表达[27]或者通过激活或抑制MAPK通路、WNT通路等促进肿瘤转移和侵袭[28 − 29]. 此外，Hippo通路失调可以通过诱导EMT和减少细胞之间或细胞与细胞外基质之间的黏附诱导肿瘤侵袭和转移发生[30 − 31]. 本课题组前期研究发现1-硝基芘暴露可以诱导Hippo-YAP通路失活，促进肺癌细胞EMT，诱导转移的发生[32]. 然而，目前仍不清楚oxy-PAHs的促肿瘤作用是否与Hippo通路有关.

    为了解9-Fluorenone的促肿瘤作用是否与Hippo-YAP通路有关，本文采用肝癌细胞暴露模型，探究了9-Fluorenone对细胞侵袭、转移等的影响，检测了MST1/2、LATS1/2、YAP等蛋白磷酸化的发生，结合免疫荧光检测了YAP-TEAD的结合，并采用YAP-TEAD阻断剂处理进一步确证了Hippo-YAP通路在9-Fluorenone促肿瘤发生中的关键作用.

    • 1.   材料与方法（Materials and methods）

      1.1.   材料与试剂

    • HepG2肝癌细胞购买自中国科学院上海细胞库，9-Fluorenone和YAP-TEAD抑制剂verteporfin购买自Sigma公司，DMEM培养基、链霉素、青霉素均购买自Gibco公司，胎牛血清购自于Biological Industries公司，Transwell小室、Matrigel基质胶购买自Corning公司，蛋白一抗（β-actin，bs-0061R；p-MST1/2，bs-3294R；MST1/2，bs-8477R；p-LATS1/2，bs-7913R；YAP，bs-3605R；p-YAP，bs-3475R）购自Bioss公司，免疫荧光一抗（YAP，ab52771；TEAD，ab58310）购自Abcam公司，荧光标记二抗（IRDye800 CW，926-32211）购自LICOR公司，反转录试剂与SYBR扩增酶购自TaKaRa公司.

      • 1.2.   细胞培养与处理

    • 将HepG2肝癌细胞于含10%血清的DMEM培养基（加100 U·mL−1链霉素和青霉素）中进行单层培养. 待HepG2细胞生长至80%时，用胰酶消化，铺细胞，将其随机分为对照组和暴露组，暴露组细胞用不同浓度（1、3、10 μmol·L−1）的9-Fluorenone处理不同时间并进行后续实验，对于YAP-TEAD阻断组，采用1 μmol·L−1 的verteporfin预处理细胞1 h后再进行9-Fluorenone暴露.

      • 1.3.   划痕实验

    • 将HepG2细胞接种于12孔板中，待细胞生长至90%时，采用无菌移液枪头划出一个宽度区域，PBS洗涤后用不同浓度（1、3、10 μmol·L−1）的9-Fluorenone暴露处理，12 h、24 h和48 h后于光学显微镜下拍照观察细胞迁移情况，计算迁移速率.

      • 1.4.   细胞侵袭实验

    • 将HepG2细胞接种于35 mm细胞培养皿中，待细胞生长至80%时，用不同浓度（1、3、10 μmol·L−1）的9-Fluorenone对细胞暴露48 h，胰酶消化处理后用无血清培养基重悬至5×105个·mL−1. 在Transwell小室内加入50 μL的Matrigel基质胶（1:8稀释），取104个细胞均匀接种到Transwell小室上方，下室中加入诱导剂即完全培养基，孵育24 h. 去掉上层的培养基，用棉签擦去上方未迁移的细胞，迁移到小室下表面的细胞用多聚甲醛固定，结晶紫染色，光学显微镜拍照计数.

      • 1.5.   Western Blot实验

    • 收集不同浓度（1、3、10 μmol·L−1）9-Fluorenone处理24 h后的细胞，用RIPA裂解液提取蛋白，用BCA试剂盒测定蛋白浓度. 采用8%的浓缩胶和分离胶进行SDS-PAGE电泳分离实验，之后90 V恒压转移至PVDF膜上，蛋白冻干粉封闭后选用不同的一抗（β-actin、p-MST1/2、MST1/2、p-LATS1/2、YAP、p-YAP）于4 ℃孵育过夜. 第二天用PBST清洗，荧光标记二抗（1:10000稀释，IRDye800 CW）避光孵育1 h，PBST清洗后使用Odyssey红外荧光成像系统对条带进行扫描.

      • 1.6.   PCR扩增实验

    • 收集不同浓度（1、3、10 μmol·L−1）9-Fluorenone处理24 h后的细胞，用Trizol提取细胞RNA，用Nanodrop测定RNA浓度. 采用反转录试剂将1 μg的RNA反转为cDNA，6倍稀释后，选用SYBR Premix Ex TaqⅡ进行实时荧光定量PCR. 扩增结果依据ΔΔCt法计算. 引物序列信息见表1.

      • 1.7.   免疫荧光实验

    • 将2 cm×2 cm的细胞玻片进行高压灭菌处理，用10×多聚赖氨酸（Poly-L）预处理后置于60 mm细胞培养皿中. 将HepG2细胞接种于玻片上，分别用10 μmol·L−1的9-Fluorenone与1 μmol·L−1的verteporfin进行暴露处理. 之后用4%多聚甲醛进行固定，0.5%Triton X-100通透处理. 用山羊血清封闭后滴加稀释好的一抗混合液（YAP和TEAD），置于湿盒中过夜. 第二天用荧光二抗混合液（羊抗兔lgG（IRDye800 CW，926-32211）和羊抗鼠lgG（bs-40296G-IRDye8））避光孵育1 h，用含DAPI抗荧光猝灭封片液进行封片，荧光显微镜下观察拍照.

      • 1.8.   数据统计

    • 所有数据为3次独立重复实验的平均值±标准差. 数据采用SPSS单因素方差分析比较组间均值差异，采用GraphPad Prism 5作图.

    2.   结果与讨论（Results and discussion）

      2.1.   oxy-PAHs的促肿瘤作用分析

    • 许多研究发现，土壤样本、河流、柴油机尾气和城市灰尘中检测到的oxy-PAHs含量高于其母体PAHs[33 − 34]. 含氧多环芳烃会引发与苯并[a]芘相似或更高水平的遗传毒性作用，表明含氧多环芳烃可能对环境多环芳烃混合物的总致癌效力有显著贡献[13]. 暴露于含氧多环芳烃后HBEC和HepG2细胞的磷酸化CHK1水平升高，此结果与肿瘤细胞增殖相关[13]. 前期研究发现，9-Fluorenone暴露可诱导肺癌细胞EMT的发生进而促进侵袭转移[32]. 然而oxy-PAHs暴露是否可影响肝癌细胞的侵袭转移，目前仍无明确数据. 本研究选用人肝癌细胞HepG2为研究对象，对其进行9-Fluorenone暴露，检测了细胞迁移、细胞侵袭能力的变化. 前期的CCK-8实验结果表明[35]，大于30 μmol·L−1的9-Fluorenone暴露会引起肝癌细胞HepG2活性的显著下降，而10 μmol·L−1的9-Fluorenone暴露对细胞活性无显著影响. 因此，本研究选择对细胞活性无显著影响的不同浓度（1、3、10 μmol·L−1）对HepG2进行暴露，以探究9-Fluorenone对细胞侵袭转移功能的影响. 划痕实验结果显示，与对照组相比，10 μmol·L−1的9-Fluorenone暴露处理48 h后细胞迁移明显增加，迁移速率变为12 h的2.36倍（图1）. Transwell小室实验发现，10 μmol·L−1的9-Fluorenone暴露处理后细胞侵袭能力为对照组的1.7倍，其他浓度下侵袭能力的变化不显著（图1）. 此结果证实，较高浓度的9-Fluorenone暴露具有一定的促肿瘤转移作用.

      肿瘤细胞的上皮间质转化（EMT）是肿瘤细胞发生侵袭和转移的重要过程[36]. EMT是上皮细胞失去细胞-细胞黏附和顶端-基底极性等特征，并获得间充质特性（如增加的运动性和侵袭性）的过程，在此过程中细胞会失去上皮标志物E-钙黏蛋白（E-cadherin）并获得间质标志物纤连蛋白（Fibronectin）等[37]. 先前研究表明，9-Fluorenone暴露可诱导肺癌细胞EMT过程的发生[19]，为了解高浓度9-Fluorenone暴露诱导肝癌细胞转移的发生是否与EMT有关，本实验检测了E-cadherin和Fibronectin基因的转录表达. 图2结果发现，10 μmol·L−1的9-Fluorenone暴露后E-cadherin基因的mRNA表达下降为对照组的0.65倍，Fibronectin基因的表达增加至1.6倍，表明高浓度的9-Fluorenone暴露促进了EMT的发生.

      • 2.2.   oxy-PAHs暴露诱导Hippo通路失活

    • Hippo通路的失调对癌症的发展有重要的影响，MST和LATS是Hippo通路激酶的核心组成部分. Hippo通路激活状态下，MST发生磷酸化后可以激活LATS的磷酸化，进而顺位激活YAP的磷酸化[38]. 研究发现MST和LATS激酶在调节重金属诱导的细胞稳态中有重要作用[39]. 为了解9-Fluorenone暴露是否影响Hippo通路上游激酶的表达，通过Western Blot检测了细胞内p-MST1/2和p-LATS1/2的表达. 结果显示，高浓度9-Fluorenone暴露后Hippo上游激酶MST和LATS的磷酸化分别降低至对照组的0.76倍和0.68倍，低浓度暴露下的变化不明显（图3）. 与此结果相同，LATS磷酸化的降低影响了YAP的磷酸化. Western Blot结果显示，9-Fluorenone暴露后p-YAP的蛋白表达降低至对照组的0.57倍（图3）. 此结果表明，9-Fluorenone暴露诱导了Hippo通路的失活，导致Hippo通路级联效应MST-LATS-YAP的磷酸化降低，该过程可能与9-Fluorenone的促肿瘤转移作用有关.

      • 2.3.   oxy-PAHs暴露影响YAP-TEAD的结合

    • Hippo通路级联效应MST-LATS-YAP的失活已在多种癌症中检出. 据报道，Hippo通路中转录共激活因子YAP发生去磷酸化后会从细胞质转移到细胞核，通过与核转录因子TEADs的相互作用，直接或间接调控肿瘤转移和侵袭相关靶基因的表达，这些靶基因可诱导肿瘤细胞形成侵袭性假足，降低细胞间黏附，降解细胞外基质，引起上皮间质转化，或通过其他信号通路如丝裂原活化蛋白激酶（mitogen-activated protein kinase, MAPK）、TGF/Smad等间接促进肿瘤的侵袭转移[31, 40]. 为检测9-Fluorenone（9-FL）暴露是否影响了YAP与TEAD的相互作用，采用免疫荧光检测了YAP和TEAD的结合效果. 与对照组相比，在9-Fluorenone暴露后，YAP与TEAD的荧光重合效果较强. 为确证这一结果，在9-Fluorenone暴露前加入YAP和TEAD的阻断剂verteporfin[41]进行预处理后，发现YAP和TEAD的荧光重合强度明显减弱，证实9-Fluorenone暴露影响了YAP与TEAD的结合与相互作用（图4），该过程可能与肿瘤EMT的发生有关.

      • 2.4.   oxy-PAHs促肿瘤转移作用与Hippo通路失活有关

    • 为明确9-Fluorenone暴露诱导肝癌细胞Hippo通路失活是否与其诱导的EMT和侵袭转移有关，采用YAP-TEAD抑制剂verteporfin预处理后检测了细胞侵袭及EMT标志基因E-cadherin和Fibronectin的转录表达，发现由高浓度9-Fluorenone暴露诱导的E-cadherin基因的mRNA水平降低以及Fibronectin基因的mRNA水平升高均得到了显著抑制，且verteporfin预处理后，细胞侵袭数目减少（图5）. 结果证实，9-Fluorenone的促肿瘤侵袭迁移作用与Hippo-YAP通路失活有关.

      前期有关硝基多环芳烃的促肿瘤研究结果发现，1-硝基芘、1-硝基萘与9-硝基蒽的促癌作用均与Hippo通路有关[32, 42]. 本研究结果与以上研究结论相似，这些研究均表明Hippo-YAP通路在多环芳烃衍生物的促肿瘤作用中至关重要. 此外，最新研究发现，Hippo通路组分在空气污染暴露诱导的肺部疾病中有重要作用. 如暴露于柴油废气颗粒的小鼠肺部和A549细胞中E-cadherin和p-YAP的表达均有下降[43]；产前柴油尾气颗粒暴露通过Hippo信号通路失调，损害胎儿肺生长，导致胎儿肺发育不良[44]. 这些结果提示，Hippo通路失调可能是空气污染暴露损伤的重要过程，在大气毒理学研究中应及时关注Hippo信号通路的调控作用.

    3.   结论（Conclusion）

    • 本研究通过肝癌细胞暴露模型发现，较高浓度9-Fluorenone暴露可促进肝癌细胞侵袭、迁移及EMT的发生，且Hippo-YAP通路在该过程中有重要作用. 9-Fluorenone暴露可通过诱导Hippo上游激酶MST、LATS以及YAP蛋白的去磷酸化，使得YAP进入细胞核内与TEAD结合，调控EMT的发生，进一步促进肝癌细胞侵袭转移. 本研究结果为含氧多环芳烃的促肿瘤活性研究提供了实验基础，对于全面评估多环芳烃及衍生物的生态和健康风险具有重要参考作用.

    参考文献 (44)

目录

/

返回文章
返回

Copyright © 2019 中国科学院生态环境研究中心